A DNA damage-activated checkpoint kinase phosphorylates tau and enhances tau-induced neurodegeneration

Human Molecular Genetics

Volumn 19, Issue 10, 2010, Pages 1930-1938

  Iijima Ando, Kanae ^a,b   Zhao, LiJuan ^a,b   Gatt, Anthony ^a,b   Shenton, Christopher ^a,b   Iijima, Koichi ^a,b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CHECKPOINT KINASE 1; CHECKPOINT KINASE 2; DNA; SERINE; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DROSOPHILA; EMBRYO; GENE MUTATION; GENE OVEREXPRESSION; IN VITRO STUDY; NERVE DEGENERATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ANIMALS; DNA DAMAGE; DROSOPHILA MELANOGASTER; ENZYME ACTIVATION; HUMANS; MUTATION; NERVE DEGENERATION; PHOSPHORYLATION; PHOSPHOSERINE; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; RECOMBINANT PROTEINS; RETINAL DEGENERATION; TAU PROTEINS;

EID: 77952482205     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddq068     Document Type: Article

References (82)

1. Lee, V.M., Goedert, M. and Trojanowski, J.Q. (2001) Neurodegenerative tauopathies. Annu. Rev. Neurosci., 24, 1121-1159.
2. Grundke-Iqbal, I., Iqbal, K., Quinlan, M., Tung, Y.C., Zaidi, M.S. and Wisniewski, H.M. (1986) Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J. Biol. Chem., 261, 6084-6089.
3. Grundke-Iqbal, I., Iqbal, K., Tung, Y.C., Quinlan, M., Wisniewski, H.M. and Binder, L.I. (1986) Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci. USA, 83, 4913-4917.
4. Kosik, K.S., Joachim, C.L. and Selkoe, D.J. (1986) Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc. Natl. Acad. Sci. USA, 83, 4044-4048.
5. Wood, J.G., Mirra, S.S., Pollock, N.J. and Binder, L.I. (1986) Neurofibrillary tangles of Alzheimer disease share antigenic determinants with the axonal microtubule-associated protein tau (tau). Proc. Natl. Acad. Sci. USA, 83, 4040-4043.
6. Brunden, K.R., Trojanowski, J.Q. and Lee, V.M. (2009) Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies. Nat. Rev. Drug Discov., 8, 783-793.
7. Biernat, J., Gustke, N., Drewes, G., Mandelkow, E.M. and Mandelkow, E. (1993) Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: distinction between PHF-like immunoreactivity and microtubule binding. Neuron, 11, 153-163.
8. Sengupta, A., Kabat, J., Novak, M., Wu, Q., Grundke-Iqbal, I. and Iqbal, K. (1998) Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules. Arch. Biochem. Biophys., 357, 299-309.
9. Cho, J.H. and Johnson, G.V. (2003) Glycogen synthase kinase 3beta phosphorylates tau at both primed and unprimed sites. Differential impact on microtubule binding. J. Biol. Chem., 278, 187-193.
10. Alonso, A.C., Grundke-Iqbal, I. and Iqbal, K. (1996) Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. Nat. Med., 2, 783-787.
11. Necula, M. and Kuret, J. (2004) Pseudophosphorylation and glycation of tau protein enhance but do not trigger fibrillization in vitro. J. Biol. Chem., 279, 49694-49703.
12. Alonso Adel, C., Mederlyova, A., Novak, M., Grundke-Iqbal, I. and Iqbal, K. (2004) Promotion of hyperphosphorylation by frontotemporal dementia tau mutations. J. Biol. Chem., 279, 34873-34881.
13. Spittaels, K., Van den Haute, C., Van Dorpe, J., Geerts, H., Mercken, M., Bruynseels, K., Lasrado, R., Vandezande, K., Laenen, I., Boon, T. et al. (2000) Glycogen synthase kinase-3beta phosphorylates protein tau and rescues the axonopathy in the central nervous system of human four-repeat tau transgenic mice. J. Biol. Chem., 275, 41340-41349.
14. Engel, T., Lucas, J.J., Gomez-Ramos, P., Moran, M.A., Avila, J. and Hernandez, F. (2006) Cooexpression of FTDP-17 tau and GSK-3beta in transgenic mice induce tau polymerization and neurodegeneration. Neurobiol. Aging, 27, 1258-1268.
15. Gomez-Sintes, R., Hernandez, F., Bortolozzi, A., Artigas, F., Avila, J., Zaratin, P., Gotteland, J.P. and Lucas, J.J. (2007) Neuronal apoptosis and reversible motor deficit in dominant-negative GSK-3 conditional transgenic mice. EMBO J., 26, 2743-2754.
16. Noble, W., Olm, V., Takata, K., Casey, E., Mary, O., Meyerson, J., Gaynor, K., LaFrancois, J., Wang, L., Kondo, T. et al. (2003) Cdk5 is a key factor in tau aggregation and tangle formation in vivo. Neuron, 38, 555-565.
17. Plattner, F., Angelo, M. and Giese, K.P. (2006) The roles of cyclin-dependent kinase 5 and glycogen synthase kinase 3 in tau hyperphosphorylation. J. Biol. Chem., 281, 25457-25465.
18. Wen, Y., Planel, E., Herman, M., Figueroa, H.Y., Wang, L., Liu, L., Lau, L.F., Yu, W.H. and Duff, K.E. (2008) Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3 beta mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing. J. Neurosci., 28, 2624-2632.
19. Gotz, J., Gladbach, A., Pennanen, L., van Eersel, J., Schild, A., David, D. and Ittner, L.M. (2009) Animal models reveal role for tau phosphorylation in human disease. Biochim. Biophys. Acta (in press). doi:10.1016/j.bbadis.2009.09.008.
20. Ballatore, C., Lee, V.M. and Trojanowski, J.Q. (2007) Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat. Rev. Neurosci., 8, 663-672.
21. Jackson, G.R., Wiedau-Pazos, M., Sang, T.-K., Wagle, N., Brown, C.A., Massachi, S. and Geschwind, D.H. (2002) Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila. Neuron, 34, 509-519.
22. Nishimura, I., Yang, Y. and Lu, B. (2004) PAR-1 kinase plays an initiator role in a temporally ordered phosphorylation process that confers tau toxicity in Drosophila. Cell, 116, 671-682.
23. Wittmann, C.W., Wszolek, M.F., Shulman, J.M., Salvaterra, P.M., Lewis, J., Hutton, M. and Feany, M.B. (2001) Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Science, 293, 711-714.
24. Mershin, A., Pavlopoulos, E., Fitch, O., Braden, B.C., Nanopoulos, D.V. and Skoulakis, E.M. (2004) Learning and memory deficits upon TAU accumulation in Drosophila mushroom body neurons. Learn. Mem., 11, 277-287.
25. Chee, F.C., Mudher, A., Cuttle, M.F., Newman, T.A., MacKay, D., Lovestone, S. and Shepherd, D. (2005) Over-expression of tau results in defective synaptic transmission in Drosophila neuromuscular junctions. Neurobiol. Dis., 20, 918-928.
26. Mudher, A., Shepherd, D., Newman, T.A., Mildren, P., Jukes, J.P., Squire, A., Mears, A., Drummond, J.A., Berg, S., MacKay, D. et al. (2004) GSK-3beta inhibition reverses axonal transport defects and behavioural phenotypes in Drosophila. Mol. Psychiatry, 9, 522-530.
27. Lee, V.M., Kenyon, T.K. and Trojanowski, J.Q. (2005) Transgenic animal models of tauopathies. Biochim. Biophys. Acta., 1739, 251-259.
28. Shulman, J.M. and Feany, M.B. (2003) Genetic modifiers of tauopathy in Drosophila. Genetics, 165, 1233-1242.
29. Fulga, T.A., Elson-Schwab, I., Khurana, V., Steinhilb, M.L., Spires, T.L., Hyman, B.T. and Feany, M.B. (2007) Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo. Nat. Cell Biol., 9, 139-148.
30. Steinhilb, M.L., Dias-Santagata, D., Mulkearns, E.E., Shulman, J.M., Biernat, J., Mandelkow, E.M. and Feany, M.B. (2007) S/P and T/P phosphorylation is critical for tau neurotoxicity in Drosophila. J. Neurosci. Res., 85, 1271-1278.
31. Steinhilb, M.L., Dias-Santagata, D., Fulga, T.A., Felch, D.L. and Feany, M.B. (2007) Tau phosphorylation sites work in concert to promote neurotoxicity in vivo. Mol. Biol. Cell, 18, 5060-5068.
32. Chatterjee, S., Sang, T.K., Lawless, G.M. and Jackson, G.R. (2009) Dissociation of tau toxicity and phosphorylation: role of GSK-3beta, MARK and Cdk5 in a Drosophila model. Hum. Mol. Genet., 18, 164-177.
33. Augustinack, J.C., Schneider, A., Mandelkow, E.M. and Hyman, B.T. (2002) Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Acta Neuropathol., 103, 26-35.
34. Matenia, D. and Mandelkow, E.M. (2009) The tau of MARK: a polarized view of the cytoskeleton. Trends. Biochem. Sci., 34, 332-342.
35. Mandelkow, E.M., Thies, E., Trinczek, B., Biernat, J. and Mandelkow, E. (2004) MARK/PAR1 kinase is a regulator of microtubule-dependent transport in axons. J. Cell Biol., 167, 99-110.
36. Thies, E. and Mandelkow, E.M. (2007) Missorting of tau in neurons causes degeneration of synapses that can be rescued by the kinase MARK2/Par-1. J. Neurosci., 27, 2896-2907.
37. Lu, T., Pan, Y., Kao, S.Y., Li, C., Kohane, I., Chan, J. and Yankner, B.A. (2004) Gene regulation and DNA damage in the ageing human brain. Nature, 429, 883-891.
38. Lovell, M.A. and Markesbery, W.R. (2007) Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer's disease. Nucleic Acids Res., 35, 7497-7504.
39. Moreira, P.I., Nunomura, A., Nakamura, M., Takeda, A., Shenk, J.C., Aliev, G., Smith, M.A. and Perry, G. (2008) Nucleic acid oxidation in Alzheimer disease. Free Radic. Biol. Med., 44, 1493-1505.
40. Stracker, T.H., Usui, T. and Petrini, J.H. (2009) Taking the time to make important decisions: the checkpoint effector kinases Chk1 and Chk2 and the DNA damage response. DNA Repair (Amst), 8, 1047-1054.
41. Reinhardt, H.C. and Yaffe, M.B. (2009) Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2 and MK2. Curr. Opin. Cell Biol., 21, 245-255.
42. Kondratov, R.V. and Antoch, M.P. (2007) Circadian proteins in the regulation of cell cycle and genotoxic stress responses. Trends Cell Biol., 17, 311-317.
43. Xu, J., Xin, S. and Du, W. (2001) Drosophila Chk2 is required for DNA damage-mediated cell cycle arrest and apoptosis. FEBS Lett., 508, 394-398.
44. Peters, M., DeLuca, C., Hirao, A., Stambolic, V., Potter, J., Zhou, L., Liepa, J., Snow, B., Arya, S., Wong, J. et al. (2002) Chk2 regulates irradiation-induced, p53-mediated apoptosis in Drosophila. Proc. Natl. Acad. Sci. USA, 99, 11305-11310.
45. Brodsky, M.H., Weinert, B.T., Tsang, G., Rong, Y.S., McGinnis, N.M., Golic, K.G., Rio, D.C. and Rubin, G.M. (2004) Drosophila melanogaster MNK/Chk2 and p53 regulate multiple DNA repair and apoptotic pathways following DNA damage. Mol. Cell Biol., 24, 1219-1231.
46. Takada, S., Kelkar, A. and Theurkauf, W.E. (2003) Drosophila checkpoint kinase 2 couples centrosome function and spindle assembly to genomic integrity. Cell, 113, 87-99.
47. Hunter, S., Apweiler, R., Attwood, T.K., Bairoch, A., Bateman, A., Binns, D., Bork, P., Das, U., Daugherty, L., Duquenne, L. et al. (2009) InterPro: the integrative protein signature database. Nucleic Acids Res., 37, D211-D215.
48. Thomas, P.D., Campbell, M.J., Kejariwal, A., Mi, H., Karlak, B., Daverman, R., Diemer, K., Muruganujan, A. and Narechania, A. (2003) PANTHER: a library of protein families and subfamilies indexed by function. Genome Res., 13, 2129-2141.
49. Steffan, J.S., Bodai, L., Pallos, J., Poelman, M., McCampbell, A., Apostol, B.L., Kazantsev, A., Schmidt, E., Zhu, Y.Z., Greenwald, M. et al. (2001) Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature, 413, 739-743.
50. Iijima, K., Chiang, H.C., Hearn, S.A., Hakker, I., Gatt, A., Shenton, C., Granger, L., Leung, A., Iijima-Ando, K. and Zhong, Y. (2008) Abeta42 mutants with different aggregation profiles induce distinct pathologies in Drosophila. PLoS ONE, 3, e1703.
51. O'Neill, T., Giarratani, L., Chen, P., Iyer, L., Lee, C.H., Bobiak, M., Kanai, F., Zhou, B.B., Chung, J.H. and Rathbun, G.A. (2002) Determination of substrate motifs for human Chk1 and hCds1/Chk2 by the oriented peptide library approach. J. Biol. Chem., 277, 16102-16115.
52. Seo, G.J., Kim, S.E., Lee, Y.M., Lee, J.W., Lee, J.R., Hahn, M.J. and Kim, S.T. (2003) Determination of substrate specificity and putative substrates of Chk2 kinase. Biochem. Biophys. Res. Commun., 304, 339-343.
53. Wang, J.W., Imai, Y. and Lu, B. (2007) Activation of PAR-1 kinase and stimulation of tau phosphorylation by diverse signals require the tumor suppressor protein LKB1. J. Neurosci., 27, 574-581.
54. Khurana, V. and Feany, M.B. (2007) Connecting cell-cycle activation to neurodegeneration in Drosophila. Biochim. Biophys. Acta., 1772, 446-456.
55. Barbato, C., Corbi, N., Canu, N., Fanciulli, M., Serafino, A., Ciotti, M., Libri, V., Bruno, T., Amadoro, G., De Angelis, R. et al. (2003) Rb binding protein Che-1 interacts with Tau in cerebellar granule neurons. Modulation during neuronal apoptosis. Mol. Cell Neurosci., 24, 1038-1050.
56. Passananti, C. and Fanciulli, M. (2007) The anti-apoptotic factor Che-1/ AATF links transcriptional regulation, cell cycle control, and DNA damage response. Cell Div., 2, 21.
57. Smale, G., Nichols, N.R., Brady, D.R., Finch, C.E. and Horton, W.E. Jr (1995) Evidence for apoptotic cell death in Alzheimer's disease. Exp. Neurol., 133, 225-230.
58. Adamec, E., Vonsattel, J.P. and Nixon, R.A. (1999) DNA strand breaks in Alzheimer's disease. Brain Res., 849, 67-77.
59. Lassmann, H., Bancher, C., Breitschopf, H., Wegiel, J., Bobinski, M., Jellinger, K. and Wisniewski, H.M. (1995) Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathol., 89, 35-41.
60. Lucassen, P.J., Chung, W.C., Kamphorst, W. and Swaab, D.F. (1997) DNA damage distribution in the human brain as shown by in situ end labeling; area-specific differences in aging and Alzheimer disease in the absence of apoptotic morphology. J. Neuropathol. Exp. Neurol., 56, 887-900.
61. Davydov, V., Hansen, L.A. and Shackelford, D.A. (2003) Is DNA repair compromised in Alzheimer's disease? Neurobiol. Aging, 24, 953-968.
62. Shao, C., Xiong, S., Li, G.M., Gu, L., Mao, G., Markesbery, W.R. and Lovell, M.A. (2008) Altered 8-oxoguanine glycosylase in mild cognitive impairment and late-stage Alzheimer's disease brain. Free Radic. Biol. Med., 45, 813-819.
63. Markesbery, W.R., Kryscio, R.J., Lovell, M.A. and Morrow, J.D. (2005) Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment. Ann. Neurol., 58, 730-735.
64. Keller, J.N., Schmitt, F.A., Scheff, S.W., Ding, Q., Chen, Q., Butterfield, D.A. and Markesbery, W.R. (2005) Evidence of increased oxidative damage in subjects with mild cognitive impairment. Neurology, 64, 1152-1156.
65. Ding, Q., Markesbery, W.R., Chen, Q., Li, F. and Keller, J.N. (2005) Ribosome dysfunction is an early event in Alzheimer's disease. J. Neurosci., 25, 9171-9175.
66. Butterfield, D.A., Poon, H.F., St Clair, D., Keller, J.N., Pierce, W.M., Klein, J.B. and Markesbery, W.R. (2006) Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease. Neurobiol. Dis., 22, 223-232.
67. Wang, J., Xiong, S., Xie, C., Markesbery, W.R. and Lovell, M.A. (2005) Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease. J. Neurochem., 93, 953-962.
68. Su, J.H., Anderson, A.J., Cummings, B.J. and Cotman, C.W. (1994) Immunohistochemical evidence for apoptosis in Alzheimer's disease. Neuroreport, 5, 2529-2533.
69. Stadelmann, C., Bruck, W., Bancher, C., Jellinger, K. and Lassmann, H. (1998) Alzheimer disease: DNA fragmentation indicates increased neuronal vulnerability, but not apoptosis. J. Neuropathol. Exp. Neurol., 57, 456-464.
70. Mandavilli, B.S. and Rao, K.S. (1996) Neurons in the cerebral cortex are most susceptible to DNA-damage in aging rat brain. Biochem. Mol. Biol. Int., 40, 507-514.
71. Ugolini, G., Cattaneo, A. and Novak, M. (1997) Co-localization of truncated tau and DNA fragmentation in Alzheimer's disease neurones. Neuroreport, 8, 3709-3712.
72. Fang-Kircher, S.G., Labudova, O., Kitzmueller, E., Rink, H., Cairns, N. and Lubec, G. (1999) Increased steady state mRNA levels of DNA-repair genes XRCC1, ERCC2 and ERCC3 in brain of patients with Down syndrome. Life Sci., 64, 1689-1699.
73. Parshad, R.P., Sanford, K.K., Price, F.M., Melnick, L.K., Nee, L.E., Schapiro, M.B., Tarone, R.E. and Robbins, J.H. (1996) Fluorescent light-induced chromatid breaks distinguish Alzheimer disease cells from normal cells in tissue culture. Proc. Natl. Acad. Sci. USA, 93, 5146-5150.
74. Jacobsen, E., Beach, T., Shen, Y., Li, R. and Chang, Y. (2004) Deficiency of the Mre11 DNA repair complex in Alzheimer's disease brains. Brain Res. Mol. Brain Res., 128,1-7.
75. Robbins, J.H., Brumback, R.A., Polinsky, R.J., Wirtschafter, J.D., Tarone, R.E., Scudiero, D.A. and Otsuka, F. (1985) Hypersensitivity to DNA-damaging agents in abiotrophies: a new explanation for degeneration of neurons, photoreceptors, and muscle in Alzheimer, Parkinson and Huntington diseases, retinitis pigmentosa, and Duchenne muscular dystrophy. Basic Life Sci., 35, 315-344.
76. Krishna, T.H., Mahipal, S., Sudhakar, A., Sugimoto, H., Kalluri, R. and Rao, K.S. (2005) Reduced DNA gap repair in aging rat neuronal extracts and its restoration by DNA polymerase beta and DNA-ligase. J. Neurochem., 92, 818-823.
77. Weissman, L., Jo, D.G., Sorensen, M.M., de Souza-Pinto, N.C., Markesbery, W.R., Mattson, M.P. and Bohr, V.A. (2007) Defective DNA base excision repair in brain from individuals with Alzheimer's disease and amnestic mild cognitive impairment. Nucleic Acids Res., 35, 5545-5555.
78. Edwards, J.A., Wang, L.G., Setlow, R.B. and Kaminskas, E. (1989) O6-methylguanine-DNA methyltransferase in lymphocytes of the elderly with and without Alzheimer's disease. Mutat Res., 219, 267-272.
79. Kinsella, T.J., Dobson, P.P., Fornace, A.J. Jr, Barrett, S.F., Ganges, M.B. and Robbins, J.H. (1987) Alzheimer's disease fibroblasts have normal repair of N-methyl-N'-nitro-N-nitrosoguanidine-induced DNA damage determined by the alkaline elution technique. Biochem. Biophys. Res. Commun., 149, 355-361.
80. Dias-Santagata, D., Fulga, T.A., Duttaroy, A. and Feany, M.B. (2007) Oxidative stress mediates tau-induced neurodegeneration in Drosophila. J. Clin. Invest., 117, 236-245.
81. Weterings, E. and Chen, D.J. (2008) The endless tale of non-homologous end-joining. Cell Res., 18, 114-124.
82. Antoni, L., Sodha, N., Collins, I. and Garrett, M.D. (2007) CHK2 kinase: cancer susceptibility and cancer therapy-two sides of the same coin? Nat. Rev. Cancer, 7, 925-936.